banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Venetoclax CAS 1257044-40-8

Venetoclax CAS 1257044-40-8

CAS TSIS TAU: 1257044-40-8
Cov Qauv Nqaij: C45H50ClN7O7S
Nqaij Molecular: 868 43900
EINECS TSIS MUAJ: 820-130-9
MDL TSIS TAU: MFCD357044408

Txhawb tshuaj

Khoom Qhia:

Khoom npe: venetoclax CAS TSIS TAU: 1257044-40-8

Txhais:

GDC-0199;

CS-1155;

RG7601;

Tshuaj& Cov Khoom Uas Lub Cev:

Cov tsos: daj khoom

Ntsuas: ≥99.0%

Qhov ceev: 1.340 ± 0.06 g / cm3 (Pom zoo)

Cov ntsiab lus npau: 697.6 ± 55.0 ℃ (Teem Tau)

Cia: 3 xyoos -20 ℃

Solubility: Insoluble (6.3E-6 g / L) (25 ℃)

Refractive index: 1.644

Venetoclax (INN, kev lag luam lub npe Venclexta ven-KLEKS-tuh, yav tas los hu ua GDC-0199, ABT-199, thiab RG7601) yog cov tshuaj lwg me me ntawm qhov ncauj tshuaj tau raug tshawb nrhiav los kho tus mob lymphocytic leukemia (CLL). Hauv xyoo 2015, Asmeskas Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj (FDA) tau tso cai rau Kev Tsim Kho Txoj Kev Kho kom haum rau venetoclax rau cov neeg mob uas muaj CLL uas tau rov mob lossis tau rov kho dua cov kev kho mob yav dhau los thiab muaj 17p kev tshem tawm caj ces hloov.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: venetoclax cas 1257044-40-8, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug